EUCTR2013-004642-41-GB进行中（未招募）不适用
Pharmacokinetics of Understudied Drugs Administered to Children per Standard of Care - Prospective study of understudied drugs in children
niversity Hospital Southampton NHS Foundation Trust0 个研究点目标入组 2,000 人开始时间: 2015年7月15日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1) Children and young people (< 21 years of age) who are receiving understudied drugs of interest per standard of care as prescribed by their treating caregiver
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 1306
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 175
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •1) Failure to obtain consent/assent
- •2) Know pregnacy as determined via interview or testing if available
- •3) If a child, who is capable of assenting, does not give their assent, even if their parent does give their consent
- •4) Aged 16 or over with mental health issues
研究者
相似试验
进行中（未招募）
不适用
A Study of the Pharmacodynamics, Pharmacokinetics, and Safety & Efficacy of ARC1779 Injection in Patients with von Willebrand Disease Type 2B - ARC1779 for VWD-2Bvon Willebrand Disease type 2BEUCTR2008-008532-82-ATMedical University of Vienna, Dept. of Clinical Pharmacology
进行中（未招募）
1 期
Study to Investigate the product Wilate in Patients with Severe Hemophilia ASevere hemophilia A (<1% FVIII:C)MedDRA version: 20.0Level: LLTClassification code 10060613Term: Hemophilia A (Factor VIII)System Organ Class: 100000004850EUCTR2016-003681-34-PLOctapharma AG55
进行中（未招募）
1 期
Study to Investigate the product Wilate in Patients with Severe Hemophilia ASevere hemophilia A (<1% FVIII:C)MedDRA version: 20.0Level: LLTClassification code 10060613Term: Hemophilia A (Factor VIII)System Organ Class: 100000004850EUCTR2016-003681-34-BGOctapharma AG55
进行中（未招募）
1 期
Study to Investigate the product Wilate in Patients with Severe Hemophilia ASevere hemophilia A (<1% FVIII:C)MedDRA version: 19.1Level: LLTClassification code 10060613Term: Hemophilia A (Factor VIII)System Organ Class: 100000004850EUCTR2016-003681-34-HUOctapharma AG55
进行中（未招募）
不适用
To determine the pharmacokinetics of human-cl rhFVIII in terms of the FVIII coagulant activity (FVIII:C) and to compare it with the licensed FVIII concentrate Kogenate/Helixate in previously treated subjects suffering from severe hemophilia A.EUCTR2008-001563-11-BGOctapharma AG22